We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+0.65%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$73.9B
AUM Growth
-$2.32B
(-3%)
Cap. Flow
-$2.03B
Cap. Flow
% of AUM
-2.75%
Top 10 Holdings %
Top 10 Hldgs %
22.54%
Holding
3,088
New
92
Increased
1,359
Reduced
1,564
Closed
46
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Moderna
MRNA
|
+$60.7M |
| 2 |
Analog Devices
ADI
|
+$46.1M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$37.3M |
| 4 |
Match Group
MTCH
|
+$28.2M |
| 5 |
GXO Logistics
GXO
|
+$19.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$89.3M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$78.9M |
| 3 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$77.4M |
| 4 |
Apple
AAPL
|
+$77M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$70.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.91% |
| 2 | Financials | 14.2% |
| 3 | Healthcare | 13.07% |
| 4 | Consumer Discretionary | 12.09% |
| 5 | Communication Services | 9.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
326
Veeva Systems
VEEV
$34.9B
| $37.7M | 0.05% |
130,934
-770
| -0.6% | -$244K |
|
327
Occidental Petroleum
OXY
$56.2B
| $37.7M | 0.05% |
1,274,623
-18,860
| -1% | -$503K |
|
328
VeriSign
VRSN
$26.5B
| $37.1M | 0.05% |
181,104
-5,252
| -3% | -$1.15M |
|
329
TE Connectivity
TEL
$63B
| $37M | 0.05% |
269,781
+2,457
| +0.9% | +$355K |
|
330
Essex Property Trust
ESS
$18.4B
| $37M | 0.05% |
115,742
-4,254
| -4% | -$1.38M |
|
331
Vulcan Materials
VMC
$36.5B
| $37M | 0.05% |
218,540
-41,857
| -16% | -$7.5M |
|
332
Steris
STE
$22.5B
| $36.8M | 0.05% |
180,326
-9,503
| -5% | -$2.03M |
|
333
Huntington Bancshares
HBAN
$35.2B
| $36.7M | 0.05% |
2,371,053
+118,032
| +5% | +$1.74M |
|
334
Cognex
CGNX
$11.4B
| $36.7M | 0.05% |
456,889
-2,192
| -0.5% | -$189K |
|
|
PARA
335
DELISTED
Paramount Global Class B
PARA
| $36.4M | 0.05% |
920,402
-19,234
| -2% | -$784K |
|
336
Mid-America Apartment Communities
MAA
$15.5B
| $36.1M | 0.05% |
193,365
-3,627
| -2% | -$681K |
|
337
Bio-Rad Laboratories Class A
BIO
$9.14B
| $36.1M | 0.05% |
48,398
-22
| -0% | -$16.5K |
|
338
Xylem
XYL
$28.2B
| $36M | 0.05% |
291,383
-2,621
| -0.9% | -$337K |
|
339
International Paper
IP
$21.7B
| $35.9M | 0.05% |
678,461
-23,077
| -3% | -$1.28M |
|
|
MASI
340
DELISTED
Masimo
MASI
| $35.9M | 0.05% |
132,626
-2,417
| -2% | -$655K |
|
341
Ventas
VTR
$47.4B
| $35.7M | 0.05% |
646,273
-13,388
| -2% | -$767K |
|
342
Palantir
PLTR
$373B
| $35.7M | 0.05% |
1,483,839
-11,076
| -0.7% | -$270K |
|
343
Caesars Entertainment
CZR
$6.14B
| $35.4M | 0.05% |
315,477
+2,215
| +0.7% | +$216K |
|
344
Teleflex
TFX
$6.15B
| $35.3M | 0.05% |
93,724
-2,389
| -2% | -$930K |
|
345
Northern Trust
NTRS
$33.6B
| $35M | 0.05% |
325,062
-44,504
| -12% | -$5.05M |
|
346
Roku
ROKU
$22.2B
| $35M | 0.05% |
111,538
-559
| -0.5% | -$211K |
|
347
Bio-Techne
TECH
$11.2B
| $34.9M | 0.05% |
287,728
-174,676
| -38% | -$21.3M |
|
348
iShares TIPS Bond ETF
TIP
$14.5B
| $34.7M | 0.05% |
271,871
-28,079
| -9% | -$3.62M |
|
349
Nordson
NDSN
$17.3B
| $34.7M | 0.05% |
145,767
-4,329
| -3% | -$1,000K |
|
350
Dollar Tree
DLTR
$24.8B
| $34.6M | 0.05% |
361,863
-2,441
| -0.7% | -$235K |
|
Similar funds
VAM
RhumbLine Advisers's Q3 2021 Portfolio in Review
As of Q3 2021, RhumbLine Advisers held 3,088 positions worth $73.9B, down 3% from $76.2B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Trading was light in Q3 2021: portfolio turnover was 4.5%. RhumbLine Advisers opened 92 new positions and exited 46, leaving the 3,088-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q3 2021 buy was GXO Logistics: 250,722 shares worth $19.7M.
- RhumbLine Advisers added most to Moderna in Q3 2021, an estimated $60.7M increase.
- RhumbLine Advisers's biggest Q3 2021 reduction was Microsoft, cutting an estimated $89.3M.
- RhumbLine Advisers fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $77.4M.
- RhumbLine Advisers's ten largest holdings make up 23% of its $73.9B portfolio in Q3 2021.
- RhumbLine Advisers opened 92 new positions and closed 46 in Q3 2021.
- RhumbLine Advisers's portfolio value fell 3% quarter-over-quarter to $73.9B.
Based on RhumbLine Advisers's 13F filing for Q3 2021, filed 12 Nov 2021.